Tumor Cytotoxicity Induced by Modulators of the CXCR4 Receptor
 12/25/2007, USP 7,312,305 B2
 06/14/2011, USP 7,960,346
 09/02/14, EP1620056
This invention relates to the use of HIV-1-, HIV-2-, SIV- or FIV- associated gp120 molecules as therapeutic agents against epithelial carcinomas.
Modulating Vaccine against HIV-1 Nef Protein Induced Lymphocyte Depletion
 5/17/2011, USP 7,943,139
This invention relates to the use of identified apoptotic motif sequences in HIV Nef as targets for a vaccine that would block Nef apoptotic motif driven pathogenesis.
Method for Treating AIDS or Cancer by Inhibiting the Secretion of Microparticles
 04/30/2013, USP 8,431,530
 07/02/2013, USP 8,476,237;
 10/08/2013, USP 8,551,943B2;
 10/22/2013, USP 8,563,506B2;
 10/28/2014, USP 8,871708B2;
European Patent:  08/14/2013, #2440570;
Germany National Patent:  #60 2010 009 528.2
Relates to the medical treatment and, in particular, to a method for treating AIDS or cancer by inhibiting the secretion of microparticles
Antimicrobial Compositions and Methods of Use Thereof
Utility Patent:  3/11/2014, USP8,669,266 B2
Relates to the medical treatment and, in particular, to antimicrobial compositions and method for treating microbial infections.